EP Patent

EP0193249A2 — Benzoyl urea derivatives having ati-tumor activity

Assigned to Duphar International Research BV · Expires 1986-09-03 · 40y expired

What this patent protects

The present invention relates to a group of new benzoyl urea derivatives of the formula having a better antitumor activity in comparison with known benzoyl urea derivatives. The compounds have been tested in several in vitro test models with different types of tumors.

USPTO Abstract

The present invention relates to a group of new benzoyl urea derivatives of the formula having a better antitumor activity in comparison with known benzoyl urea derivatives. The compounds have been tested in several in vitro test models with different types of tumors.

Drugs covered by this patent

Patent Metadata

Patent number
EP0193249A2
Jurisdiction
EP
Classification
—
Expires
1986-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Duphar International Research BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.